Background

Due to their many adverse effects, oral anticancer agents (OAAs) result in high discontinuation rates and low adherence. While evidence exists that mitigating these adverse effects improves adherence, there is a lack of data demonstrating the impact health system specialty pharmacy (HSSP) pharmacists have on improving discontinuation rates.

Objectives

Compare discontinuation rates in patients on oral anticancer medication before and after a pharmacist-led check-in protocol is put in place to contact patients within 14 days from therapy start.

Read the Outcomes Study by submitting the form below.

​